US Patent Issued to Regeneron Pharmaceuticals on May 26 for "Methods and compositions for targeted genetic modification using paired guide RNAs" (New York, Washington, New Jersey Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,698, issued on May 26, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Methods and compositions for targeted genetic modification using paired guide RNAs" was invented by David Frendewey (New York), Ka-Man Venus Lai (Seattle), Wojtek Auerbach (Ridgewood, N.J.), Gustavo Droguett (New City, N.Y.), Anthony Gagliardi (Hopewell Junction, N.Y.), David M. Valenzuela (Yorktown Heights, N.Y.), Vera Voronina (Sleepy Hollow, N.Y.), Lynn Macdonald (Harrison, N.Y.), Andrew J. Murphy (Croton-on-Hudson, N.Y.) and George D. Yancopoulos (Yorktown Heights, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods are provided for ...